£50.00

It has never been this cheap. We have no record of a lower price.

£50 today · cheaper than every other day in the last 3 months

Lipid lowering drugs in induced non-alcoholic steatohepatitis in rats: Role of Atorvastatin and Omega 3

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 25 days · 25 data points (no recent data)

Historical
Generating forecast…
£50.00 £47.50 £48.50 £49.50 £50.50 £51.50 £52.50 22 August 2026 28 August 2026 03 September 2026 09 September 2026 15 September 2026
View at Amazon ↗

Price data last checked 66 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 25 days • 1 price levels

Days at Price
25 days 0 6 13 19 25 £50 Days at Price

Price Analysis

Most common price: £50 (25 days, 100.0%)

Price range: £50 - £50

Price levels: 1 different prices over 25 days

Description

Non-alcoholic steatohepatitis (NASH) has been recognized as an important and relatively common disease in relation to obesity. It occurs in context of metabolic syndrome. NASH has a bad prognosis as it leads to hepatocellular carcinoma and its association with coronary vascular diseases. To date the therapeutic options are limited due to complex nature of pathogenesis. Recently cholesterol has been linked to progression of benign steatosis to NASH. Targeting metabolic syndrome components and factors related to progression has been proposed for treatment. Aim of the work in this book is to investigate if Atorvastatin and Omega 3 and their combination have a protective role in high fat diet induced NASH and to clarify their mechanisms of action. Atorvastatin improved lipid profile, decreased inflammation and oxidative stress but did not improve insulin resistance or body weight. Histopathologically it prevented steatosis and decreased inflammation. Fish oil improved lipid profile, decreased inflammation and oxidative stress, improved insulin resistance and decreased body weight, combination led to complementary action of both drugs and was more beneficial.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
12 October 2016
Listed Since
04 November 2016

Barcode

No barcode data available

Similar Products You Might Like

Non-Alcoholic Fatty Liver Disease: Diagnosis and Treatment
83% match

Non-Alcoholic Fatty Liver Disease: Diagnosis and Treatment

£116.69 23 Oct 2026
Hepatic De Novo Lipogenesis and Regulation of Metabolism
82% match

Hepatic De Novo Lipogenesis and Regulation of Metabolism

Springer

£112.02 26 Oct 2026
A Clinician's Guide to Non-Alcoholic Fatty Liver Disease
81% match

A Clinician's Guide to Non-Alcoholic Fatty Liver Disease

£115.65 03 Nov 2026
Therapeutic Potential of Fenugreek and Curcuma on Diabetes in Rats
81% match

Therapeutic Potential of Fenugreek and Curcuma on Diabetes in Rats

£78.00 12 Nov 2026
Trends in Cox-2 Inhibitor Research
81% match

Trends in Cox-2 Inhibitor Research

£101.25 27 Oct 2026
Liver Diseases: Biochemical Mechanisms and New Therapeutic Insights: 001
80% match

Liver Diseases: Biochemical Mechanisms and New Therapeutic Insights: 001

CRC Press

£145.99 26 Oct 2026
Effect of Quercetin on Copper Sulphate Induced Proventriculitisin rats: RESEARCH STUDY
80% match

Effect of Quercetin on Copper Sulphate Induced Proventriculitisin rats: RESEARCH STUDY

LAP Lambert Academic Publishing

£58.00 23 Oct 2026
L-Arginine: Structure, Dietary Sources & Beneficial Effects
80% match

L-Arginine: Structure, Dietary Sources & Beneficial Effects

Price unavailable
An Introduction to Drug Carriers (Biochemistry Research Trends)
80% match

An Introduction to Drug Carriers (Biochemistry Research Trends)

Price unavailable
Atomic and Molecular Cluster Research
80% match

Atomic and Molecular Cluster Research

£126.23 04 Nov 2026
Update of Non-Pharmacological Therapy for Heart Failure
80% match

Update of Non-Pharmacological Therapy for Heart Failure

Springer

£73.11 30 Oct 2026
Stroke and Atrial Fibrillation: An Integrated Study
80% match

Stroke and Atrial Fibrillation: An Integrated Study

£110.87 27 Oct 2026
Clinical Aspects of Liver and Gastrointestinal Tract Diseases
80% match

Clinical Aspects of Liver and Gastrointestinal Tract Diseases

£110.91 27 Oct 2026
Nutraceuticals and Alzheimer's disease: Potent role of nutraceuticals for regression of Alzheimer's disease in aged rats
79% match

Nutraceuticals and Alzheimer's disease: Potent role of nutraceuticals for regression of Alzheimer's disease in aged rats

LAP Lambert Academic Publishing

£69.00 12 Nov 2026
Chronic Liver Disease: Causes, Evaluation and Therapeutics
79% match

Chronic Liver Disease: Causes, Evaluation and Therapeutics

£109.70 27 Oct 2026
79% match

Phytochemical Interventions in Mitigating Neurodegeneration: Targeting Proteinopathies

Wiley

£180.00 26 Oct 2026
The Evolving Landscape of Liver Cirrhosis Management
79% match

The Evolving Landscape of Liver Cirrhosis Management

Springer

£95.71 21 Oct 2026
Multifunctional Nano pharmaceuticals for Biomedical Applications
79% match

Multifunctional Nano pharmaceuticals for Biomedical Applications

Elsevier

£157.99 20 Oct 2026
A Closer Look at Glycation (Biochemistry Research Trends)
79% match

A Closer Look at Glycation (Biochemistry Research Trends)

£693.79 02 Nov 2026
Laser Optofluidics in Fighting Multiple Drug Resistance
79% match

Laser Optofluidics in Fighting Multiple Drug Resistance

£149.95 05 Nov 2026
دراسة مرضية عن داء الأبواغ الدقيقة في بعض الحيوانات المختبرية
79% match

دراسة مرضية عن داء الأبواغ الدقيقة في بعض الحيوانات المختبرية

£62.00 04 Nov 2026
Bioactive Natural Products in Drug Discovery
79% match

Bioactive Natural Products in Drug Discovery

£111.62 27 Oct 2026
Adverse Drug Reactions: Mechanisms and Management
79% match

Adverse Drug Reactions: Mechanisms and Management

Allied Health Press

£141.67 29 Oct 2026
79% match

Liposomal Nanocarriers in Oncology

Wiley

£166.00 27 Oct 2026